Enliven Therapeutics Inc (NASDAQ:ELVN) Has Recovered 64.4% So Far, But Another -0.51% Loss Is Possible.
Enliven Therapeutics Inc (NASDAQ:ELVN)’s traded shares stood at 0.35 million during the last session, with the company’s beta value hitting 1.09. At the close of